Effect of STRAIN COUNTER-STRAIN ON PATIENTS WITH ANKLE SPRAINS

April 24, 2025 updated by: Atef Nadier, Al-Ahliyya Amman University

Effect of STRAIN COUNTER-STRAIN ON PATIENTS WITH ACUTE and POSTACUTE LATERAL ANKLE SPRAINS

patients (male and female) will be participate at the study complain of acute to subacute ankle sprain.

Orthopedic surgeons who will be responsible for the diagnosis of the all cases. The patients will under went to anterior drawer test .

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Age, six, height, weight (Between 15 to 40 y).

  1. FAAM TEST
  2. single-leg loading (SLL) test, fOR proprioception
  3. Knee to Wall Dorsiflexion Lunge Test for Ankle dorsiflexion ROM. From sitting.(MODIFIED).
  4. Pain (VAS)

Study Type

Interventional

Enrollment (Estimated)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Jordan
      • Amman, Jordan, 19111
        • Al-Ahliyya Amman University
        • Contact:
          • Atef abulalim nadier, assistant professor
      • Amman, Jordan, 19111
        • Hossam Metwally
        • Contact:
          • ahmed fikery Al-Ahliyya Amman University, assistant professor
          • Phone Number: 0962797192843
          • Email: h.metwally@ammanu.edo.jo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

acute to subacute ankle sprain positive ankle anterior drawer test

Exclusion Criteria:

  • Recurrent ankle sprain,

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: group a
STRAIN COUNTER-STRAIN technique will be done plus Traditional physical therapy: ( ice application , anterior-to-posterior talar mobilization , orthoses, therapeutic exercise resistance or intensity, Stretch the gastrocnemius-soleus muscle group , partial to full weight-bearing and balance board exercises).
Other: EXERCISE TRAINING WITH OR WITHOUT MEDICATION
ice every 2 waking hours during the first 24 to 48 hours,a brace early in rehabilitation , strain counters strain technique
Active Comparator: group b
(Traditional physical therapy) : Ice application , anterior-to-posterior talar mobilization , orthoses, therapeutic exercise resistance or intensity, Stretch the gastrocnemius-soleus muscle group , partial to full weight-bearing balance board exercises.
Other: EXERCISE TRAINING WITH OR WITHOUT MEDICATION
ice every 2 waking hours during the first 24 to 48 hours,a brace early in rehabilitation , strain counters strain technique
Other: Exercise
RICE, anterior-to-posterior talar mobilization, orthoses

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
assess Pain changes
Time Frame: At base line and after 3months of treatment
be visual analogue scale
At base line and after 3months of treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Foot and Ankle Ability Measure(FAAM TEST)
Time Frame: At base line and after 3months of treatment
changes of ankle function will be recorded by FAAM questionnaire
At base line and after 3months of treatment
Changes of Knee to Wall Dorsiflexion Lunge Test
Time Frame: at base line and after 3month of treatment
functional range of motion for ankle Dorsiflexion
at base line and after 3month of treatment
changes of single-leg loading (SLL) test
Time Frame: at base line and after 3month of treatment
the test assess ankle proprioception
at base line and after 3month of treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Al-Ahliyya Amman University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 1, 2025

Primary Completion (Estimated)

December 28, 2025

Study Completion (Estimated)

March 28, 2026

Study Registration Dates

First Submitted

April 24, 2025

First Submitted That Met QC Criteria

April 24, 2025

First Posted (Actual)

May 1, 2025

Study Record Updates

Last Update Posted (Actual)

May 1, 2025

Last Update Submitted That Met QC Criteria

April 24, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 10557 (Fred Hutch/University of Washington Cancer Consortium)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sports Medicine Injuries

Clinical Trials on EXERCISE TRAINING WITH OR WITHOUT MEDICATION

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe